UBS Group AG lowered its stake in M.D.C. Holdings, Inc. (NYSE:MDC) by 6.9% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 7,607 shares of the construction company’s stock after selling 560 shares during the period. UBS Group AG’s holdings in M.D.C. Holdings were worth $228,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently modified their holdings of the company. Ameritas Investment Partners Inc. purchased a new stake in shares of M.D.C. Holdings during the first quarter valued at about $108,000. Glen Harbor Capital Management LLC boosted its stake in shares of M.D.C. Holdings by 18.8% in the first quarter. Glen Harbor Capital Management LLC now owns 3,876 shares of the construction company’s stock valued at $116,000 after buying an additional 612 shares during the period. Acrospire Investment Management LLC purchased a new stake in shares of M.D.C. Holdings during the first quarter valued at about $125,000. State of Alaska Department of Revenue boosted its stake in shares of M.D.C. Holdings by 2.2% in the first quarter. State of Alaska Department of Revenue now owns 4,562 shares of the construction company’s stock valued at $137,000 after buying an additional 100 shares during the period. Finally, Cambridge Investment Research Advisors Inc. purchased a new stake in shares of M.D.C. Holdings during the first quarter valued at about $255,000. 81.16% of the stock is currently owned by institutional investors and hedge funds.

M.D.C. Holdings, Inc. (MDC) traded up 0.20% during trading on Friday, hitting $34.56. The stock had a trading volume of 593,292 shares. M.D.C. Holdings, Inc. has a 12 month low of $21.25 and a 12 month high of $36.92. The company has a market cap of $1.79 billion, a PE ratio of 14.64 and a beta of 1.36. The company’s 50 day moving average is $35.37 and its 200-day moving average is $31.74.

M.D.C. Holdings (NYSE:MDC) last announced its quarterly earnings data on Tuesday, August 1st. The construction company reported $0.64 EPS for the quarter, topping the Zacks’ consensus estimate of $0.61 by $0.03. M.D.C. Holdings had a return on equity of 9.25% and a net margin of 4.76%. The firm had revenue of $648.97 million for the quarter, compared to the consensus estimate of $623.95 million. During the same quarter last year, the business posted $0.55 earnings per share. The firm’s revenue was up 13.6% compared to the same quarter last year. On average, equities research analysts predict that M.D.C. Holdings, Inc. will post $2.48 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 23rd. Investors of record on Wednesday, August 9th will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Monday, August 7th. This represents a $1.00 dividend on an annualized basis and a yield of 2.89%.

TRADEMARK VIOLATION NOTICE: “UBS Group AG Sells 560 Shares of M.D.C. Holdings, Inc. (NYSE:MDC)” was first published by Daily Political and is the property of of Daily Political. If you are viewing this piece of content on another website, it was illegally stolen and reposted in violation of international copyright & trademark laws. The legal version of this piece of content can be accessed at https://www.dailypolitical.com/2017/08/06/ubs-group-ag-sells-560-shares-of-m-d-c-holdings-inc-nysemdc.html.

Several analysts have recently issued reports on MDC shares. Zacks Investment Research raised M.D.C. Holdings from a “hold” rating to a “buy” rating and set a $40.00 price objective on the stock in a report on Thursday, June 29th. BidaskClub cut M.D.C. Holdings from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Deutsche Bank AG upped their price objective on M.D.C. Holdings from $27.00 to $33.00 and gave the stock a “hold” rating in a report on Thursday. Citigroup Inc. cut M.D.C. Holdings from a “buy” rating to a “neutral” rating in a report on Wednesday, May 10th. Finally, Bank of America Corporation reaffirmed an “underperform” rating and set a $27.00 price objective (up from $24.00) on shares of M.D.C. Holdings in a report on Wednesday, June 28th. Three investment analysts have rated the stock with a sell rating and five have issued a hold rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $31.20.

In related news, Director David E. Blackford sold 26,250 shares of M.D.C. Holdings stock in a transaction that occurred on Wednesday, August 2nd. The stock was sold at an average price of $36.11, for a total transaction of $947,887.50. Following the transaction, the director now owns 40,928 shares in the company, valued at $1,477,910.08. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Michael A. Berman sold 52,500 shares of M.D.C. Holdings stock in a transaction that occurred on Monday, May 15th. The stock was sold at an average price of $35.60, for a total value of $1,869,000.00. The disclosure for this sale can be found here. In the last quarter, insiders have sold 189,000 shares of company stock worth $6,602,663. 25.30% of the stock is currently owned by company insiders.

M.D.C. Holdings Company Profile

M.DC Holdings, Inc is engaged in two primary operations, including homebuilding and financial services. The Company’s segments include West, including segments located in Arizona, California, Nevada and Washington; Mountain, including segments located in Colorado and Utah; East, including segments located in Virginia, Florida and Maryland, which includes Pennsylvania and New Jersey; mortgage operations, including HomeAmerican Mortgage Corporation, and Other, which includes Allegiant Insurance Company, Inc, StarAmerican Insurance Ltd., American Home Insurance Agency, Inc and American Home Title and Escrow Company.

Institutional Ownership by Quarter for M.D.C. Holdings (NYSE:MDC)

Receive News & Ratings for M.D.C. Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.